CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 156 participants.
Also called NCT05422534
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 156 participants
- Registry
-
NCT05422534
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05422534. Randomized; double masking; primary purpose prevention. Start 2023-06-01 (actual); primary completion 2027-06-20 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
- Condition
- End Stage Renal Disease
- Intervention (Dietary supplement)
- CoQ10
- Intervention (Drug)
- Placebo
- Intervention (Behavioral)
- HB-HIIT
- Intervention (Behavioral)
- Observational
- Lead sponsor
- Vanderbilt University Medical Center
- Collaborator
- University of California, Davis
Record details
- Record id
cardio:ct-nct05422534- Content hash
1ea70b8fa8490e05f69d77ae1115e569b0ec8b4879aa8bd32e4b47a1482dfd49